Healthcare -
Drug Manufacturers - General - NYSE - US
$ 10.885
-4.41 %
$ 2.81 B
Market Cap
3.19
P/E
OGN - COST OF REVENUE
Cost of Revenue OGN - Organon & Co.
2.69 B
LAST VALUE
8.25%
2 YEAR CAGR
3.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR